Qing hua Yu

Dr. Qing hua Yu


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 March 2020 in Gut Microbes
Verified
Journal Article
Closed access
HWHaiqin Wu
Haiqin Wu
SXShuang Xie
Shuang Xie
JMJinfeng Miao
Jinfeng Miao
YLYuchen Li
Yuchen Li
ZWZhihua Wang
Zhihua Wang
QYQing hua Yu
Qing hua Yu
Little is known about the regulatory effect of microbiota on the proliferation and regeneration of ISCs. Here, we found that L. reuteri stimulated the proliferation of intestinal epithelia by increasing the expression of R-spondins and thus activating the Wnt/β-catenin pathway. The proliferation-stimulating effect of Lactobacillus on repair is further enhanced under TNF -induced intestinal mucosal damage, and the number of Lgr5+ cells is maintained. Moreover, compared to the effects of C. rodentium on the induction of intestinal inflammation and crypt hyperplasia in mice, L. reuteri protected the intestinal mucosal barrier integrity by moderately modulating the Wnt/β-catenin signaling pathway to avoid overactivation. L. reuteri had the ability to maintain the number of Lgr5+ cells and stimulate intestinal epithelial proliferation to repair epithelial damage and reduce proinflammatory cytokine secretion in the intestine and the LPS concentration in serum. Moreover, activation of the Wnt/β-catenin pathway also induced differentiation toward Paneth cells and increased antimicrobial peptide expression to inhibit C. rodentium colonization. The protective effect of Lactobacillus against C. rodentium infection disappeared upon application of the Wnt antagonist Wnt-C59 in both mice and intestinal organoids. This study demonstrates that Lactobacillus is effective at maintaining intestinal epithelial regeneration and homeostasis as well as at repairing intestinal damage after pathological injury and is thus a promising alternative therapeutic method for intestinal inflammation.

19 February 2018 in Cell Death & Differentiation
Verified
Journal Article
Closed access
PDF file
QHQihang Hou
Qihang Hou
LYLulu Ye
Lulu Ye
HLHaofei Liu
Haofei Liu
LHLulu Huang
Lulu Huang
QYQian Yang
Qian Yang
QYQing hua Yu
Qing hua Yu

18 November 2022 in Environmental Research
Verified
Journal Article
Closed access
SXShuang Xie
Shuang Xie
RZRui Zhang
Rui Zhang
ZLZhaoyan Li
Zhaoyan Li
CLChunru Liu
Chunru Liu
YCYanyu Chen
Yanyu Chen
QYQing hua Yu
Qing hua Yu

5 March 2020 in Veterinary Research
Verified
Journal Article
Open access
PDF file
LZLinda Zhu
Linda Zhu
XLXiaoxi Lu
Xiaoxi Lu
LLLi Liu
Li Liu
JVJosef Voglmeir
Josef Voglmeir
Xiang ZhongXiang Zhong
Xiang Zhong
QYQing hua Yu
Qing hua Yu
Akkermansia muciniphila, a novel mucin-degrading bacterium, has been demonstrated to prevent the development of obesity and related complications. However, whether it can protect poultry from intestinal mucosal damage by enteropathogens has never been mentioned. In this study, we found that A. muciniphila colonized in the intestine and then relieved intestinal mucosal damage in chicks caused by S. pullorum, including anatomical and morphological damage, alleviation of body weight and intestinal inflammation. The repair process activated by A. muciniphila is accompanied by an increase in the number of goblet cells in the chick’s intestine and an up-regulation of Mucin 2 and trefoil factor 2 (Tff2). In addition, we also demonstrate that A. muciniphila improved colon length, crypt depth, increased the proliferating cell nuclear antigen, with the accelerated proliferation of intestinal epithelium through Wnt/β-catenin signaling pathway, thereby restoring the damaged intestinal mucosa. This study suggests that A. muciniphila activates the proliferation of intestinal cells protecting the intestinal barrier, thus relieving infection with S. pullorum in chickens.

2 December 2019 in Journal of Agricultural and Food Chemistry
Verified
Journal Article
Closed access
SXShuang Xie
Shuang Xie
SZShiyi Zhao
Shiyi Zhao
LJLan Jiang
Lan Jiang
LLLinhao Lu
Linhao Lu
QYQian Yang
Qian Yang
QYQing hua Yu
Qing hua Yu

23 May 2017 in Frontiers in Immunology
Verified
Journal Article
Open access
QHQihang Hou
Qihang Hou
LYLulu Ye
Lulu Ye
LHLulu Huang
Lulu Huang
QYQing hua Yu
Qing hua Yu
The intestine is home to trillions of microorganisms, and the vast diversity within this gut microbiota exists in a balanced state to protect the intestinal mucosal barrier. Research into the association of the intestinal microbiota with health and disease (including diet, nutrition, obesity, inflammatory bowel disease and cancer) continues to expand, with the field advancing at a rapid rate. Intestinal stem cells (ISCs) are the fundamental component of the mucosal barrier; they undergo continuous proliferation to replace the epithelium, which is also intimately involved in intestinal diseases. The intestinal microbiota, such as Lactobacillus, communicates with intestinal stem cells both directly and indirectly to regulate the proliferation and differentiation of ISCs. Moreover, Salmonella infection significantly decreased the expression of intestinal stem cell markers Lgr5 and Bmi1. However, the detailed interaction of intestinal microbiota and ISCs are still unclear. This review considers the progress of research on the model and niches of intestinal stem cells, as well as the complex interplay between the gut microbiota and ISCs, which will be crucial for explaining the mechanisms of intestinal diseases related to imbalances in the intestinal microbiota and ISCs.